The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection

Hearing Research

Volumn 278, Issue 1-2, 2011, Pages 69-76

  Wise, Andrew K ^a,b   Tu, Tian ^a,b   Atkinson, Patrick J ^a,b   Flynn, Brianna O ^a   Sgro, Beatrice E ^a   Hume, Cliff ^c   O'Leary, Stephen J ^a,b   Shepherd, Robert K ^a,b   Richardson, Rachael T ^a,b  

^a BIONIC EAR INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AMINOGLYCOSIDE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; NEUROTROPHIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL COMPARTMENTALIZATION; CELL SURVIVAL; COCHLEA DUCT; COCHLEAR NERVE; CONTROLLED STUDY; CORTI ORGAN; DISEASE DURATION; DRUG EFFICACY; FEMALE; GUINEA PIG; HEARING IMPAIRMENT; HUMAN; HUMAN CELL; LATERAL VESTIBULAR NUCLEUS; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SPIRAL GANGLION; SPIRAL LIGAMENT; STRIA VASCULARIS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL COUNT; CELL SURVIVAL; DEAFNESS; FEMALE; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GUINEA PIGS; MALE; NERVE GROWTH FACTORS; NEURONS; NEUROTROPHIN 3; RECOMBINANT PROTEINS; SPIRAL GANGLION; TIME FACTORS;

EID: 79960986804     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2011.04.010     Document Type: Article

References (34)

1. Agterberg M.J., Versnel H., van Dijk L.M., de Groot J.C., Klis S.F. Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J. Assoc. Res. Otolaryngol. 2009, 10:355-367.
2. Agterberg M.J., Versnel H., De Groot J.C., Smoorenburg G.F., Albers F.W., Klis S.F. Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs. Hear Res. 2008, 244:25-34.
3. Altschuler R.A., Cho Y., Ylikoski J., Pirvola U., Magal E., Miller J.M. Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors. Ann. N. Y Acad. Sci. 1999, 884:305-311.
4. Chikar J.A., Colesa D.J., Swiderski D.L., Polo A.D., Raphael Y., Pfingst B.E. Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear Res. 2008, 245:24-34.
5. Coyne C.B., Bergelson J.M. CAR: a virus receptor within the tight junction. Adv. Drug Deliv. Rev. 2005, 57:869-882.
6. Ernfors P., Merlio J.P., Persson H. Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development. Eur. J. Neurosci. 1992, 4:1140-1158.
7. Ernfors P., Duan M.L., ElShamy W.M., Canlon B. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat. Med. 1996, 2:463-467.
8. Fritzsch B., Silos-Santiago I., Bianchi L.M., Farinas I. The role of neurotrophic factors in regulating the development of inner ear innervation. Trends Neurosci. 1997, 20:159-164.
9. Gillespie L.N., Clark G.M., Marzella P.L. Delayed neurotrophin treatment supports auditory neuron survival in deaf guinea pigs. Neuroreport 2004, 15:1121-1125.
10. Gillespie L.N., Clark G.M., Bartlett P.F., Marzella P.L. BDNF-induced survival of auditory neurons in vivo: cessation of treatment leads to accelerated loss of survival effects. J. Neurosci. Res. 2003, 71:785-790.
11. Glueckert R., Bitsche M., Miller J.M., Zhu Y., Prieskorn D.M., Altschuler R.A., Schrott-Fischer A. Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J. Comp. Neurol. 2008, 507:1602-1621.
12. Hardie N.A., Shepherd R.K. Sensorineural hearing loss during development: morphological and physiological response of the cochlea and auditory brainstem. Hear Res. 1999, 128:147-165.
13. Lalwani A., Walsh B., Reilly P., Carvalho G., Zolotukhin S., Muzyczka N., Mhatre A. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther. 1998, 5:277-281.
14. Lalwani A.K., Han J.J., Castelein C.M., Carvalho G.J., Mhatre A.N. In vitro and in vivo assessment of the ability of adeno-associated virus-brain-derived neurotrophic factor to enhance spiral ganglion cell survival following ototoxic insult. Laryngoscope 2002, 112:1325-1334.
15. McGuinness S.L., Shepherd R.K. Exogenous BDNF rescues rat spiral ganglion neurons in vivo. Otol Neurotol 2005, 26:1064-1072.
16. Miller J.M., Chi D.H., O'Keeffe L.J., Kruszka P., Raphael Y., Altschuler R.A. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int. J. Dev. Neurosci. 1997, 15:631-643.
17. Mittereder N., March K.L., Trapnell B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 1996, 70:7498-7509.
18. Nadol J.B., Young Y.S., Glynn R.J. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann. Otol Rhinol Laryngol. 1989, 98:411-416.
19. Nakaizumi T., Kawamoto K., Minoda R., Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol. Neuro. Otol. 2004, 9:135-143.
20. Pettingill L.N., Richardson R.T., Wise A.K., O'Leary S.J., Shepherd R.K. Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system. IEEE Trans. Biomed. Eng. 2007, 54:1138-1148.
21. Sellick P., Layton M.G., Rodger J., Robertson D. A method for introducing non-silencing siRNA into the guinea pig cochlea in vivo. J. Neurosci. Methods 2008, 167:237-245.
22. Shepherd R.K., Clark G.M. Progressive ototoxicity of neomycin monitored using derived brainstem response audiometry. Hear Res. 1985, 18:105-110.
23. Shepherd R.K., Coco A., Epp S.B. Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hear Res. 2008, 242:100-109.
24. Shepherd R.K., Coco A., Epp S.B., Crook J.M. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J. Comp. Neurol. 2005, 486:145-158.
25. Shibata S.B., Cortez S.R., Beyer L.A., Wiler J.A., Di Polo A., Pfingst B.E., Raphael Y. Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp. Neurol. 2010, 223:464-472.
26. Staecker H., Gabaizadeh R., Federoff H., Van De Water T.R. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol. Head Neck Surg. 1998, 119:7-13.
27. Staecker H., Kopke R., Malgrange B., Lefebvre P., Van De Water T.R. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996, 7:889-894.
28. Stankovic K., Rio C., Xia A., Sugawara M., Adams J.C., Liberman M.C., Corfas G. Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear. J. Neurosci. 2004, 24:8651-8661.
29. Waehler R., Russell S.J., Curiel D.T. Engineering targeted viral vectors for gene therapy. Nat. Rev. Genet. 2007, 8:573-587.
30. Webster M., Webster D.B. Spiral ganglion neuron loss following organ of corti loss: a quantitative study. Brain Res. 1981, 212:17-30.
31. Wise A.K., Richardson R., Hardman J., Clark G., O'Leary S. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J. Comp. Neurol. 2005, 487:147-165.
32. Wise A.K., Hume C.R., Flynn B.O., Jeelall Y.S., Suhr C.L., Sgro B.E., O'Leary S.J., Shepherd R.K., Richardson R.T. Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea. Mol. Ther. 2010, 18:1111-1122.
33. Yagi M., Kanzaki S., Kawamoto K., Shin B., Shah P.P., Magal E., Sheng J., Raphael Y. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J. Assoc. Res. Otolaryngol. 2000, 1:315-325.
34. Ylikoski J., Pirvola U., Moshnyakov M., Palgi J., Arumae U., Saarma M. Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear. Hear Res. 1993, 65:69-78.